Bloodflow in the orbital artery and central retinal artery was studied by triplex scanning in 35 patients with normal pressure glaucoma, and 14 subjects without signs of glaucoma. Significant differences in the studied parameters were detected in the patients in comparison with the controls: decreased linear bloodflow velocity in the orbital (p < 0.01) and central retinal arteries (p < 0.01), increased peripheral resistance indexes in both arteries (p < 0.05) in patients with normal pressure glaucoma, and decreased bloodflow velocity in the central retinal artery in primary open-angle glaucoma (p < 0.05). The time course of hemodynamic parameters was different in normal pressure and primary open-angle glaucoma. These data confirm the important role of vascular disorders in the pathogenesis of normal pressure glaucoma.

Download full-text PDF

Source

Publication Analysis

Top Keywords

normal pressure
20
patients normal
12
central retinal
12
pressure glaucoma
12
retinal artery
8
bloodflow velocity
8
primary open-angle
8
open-angle glaucoma
8
glaucoma
6
normal
5

Similar Publications

Study Objectives: Insomnia with objective short sleep duration is associated with increased hypertension risk. We aimed to explore the mechanism underlying the association between objective short sleep duration and hypertension in patients with chronic insomnia disorder (CID) by multi-omics.

Methods: CID was defined according to International Classification of Sleep Disorders-3, and objective short sleep was based on the median value of total sleep time of the overall subjects during an overnight polysomnography.

View Article and Find Full Text PDF

Osteoarthritis (OA) remains a significant clinical challenge, with current treatments like sodium hyaluronate injections offering limited efficacy due to suboptimal lubrication and rapid degradation. In this study, we explored an advanced solution to these issues by investigating the colubrication mechanism of a composite biolubricant consisting of 2-methacryloyloxyethyl phosphorylcholine-modified chitosan (CS-MPC) and chondroitin sulfate-modified chitosan nanoparticles (CS-ChS NPs) using molecular dynamics (MD) simulations. Results show that the composite lubricant outperforms individual CS-MPC or CS-ChS NPs, exhibiting a lower coefficient of friction (COF) and a superior load-bearing capacity.

View Article and Find Full Text PDF

Pharmacologic beta-blockade is a well-established therapy for reducing adverse effects from sympathetic overactivity in cardiovascular diseases, such as heart failure. Despite decades of research efforts, in vivo cardiac functional studies utilizing genetic animal models remain scant. We generated a mouse model of cardiomyocyte-specific deletion of beta-1 adrenergic receptor (ADRB1) , the primary subtype expressed in cardiac myocytes, and demonstrated the role for ADRB1 in the maintenance of cardiac function at baseline and during exposure to increase in cardiac afterload by transient aortic occlusion and increasing heart rates (HRs) via atrial pacing.

View Article and Find Full Text PDF

Background: Hypertension is a major cardiovascular risk factor, yet traditional care often results in suboptimal blood pressure (BP) control at the population level. We implemented a remote hypertension management program that monitored home BP and titrated medications per algorithm. This study assessed the program's long-term effects by examining participants' office BP up to 42 months post-enrollment.

View Article and Find Full Text PDF

Percutaneous interventions have become significant in the management of congenital heart diseases, with transcatheter procedures being increasingly used for valve dysfunction, particularly for cases requiring repetitive surgeries. This abstract presents a successful transcatheter valve-in-valve implantation in a 16-year-old patient with severe tricuspid regurgitation following a bioprosthetic tricuspid valve replacement. The procedure involved transcatheter tricuspid valve implantation using the Mammoth 25x40 mm balloon catheter and the 26 mm Myval transcatheter heart valve system (Meril Life Sciences Pvt.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!